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Abstract 
 Introduction: Newcastle Disease is a highly contagious and 
commonly fatal viral poultry disease. The study was carried out to determine 
the efficacy of Newcastle Disease (NDV) vaccines sold at open market in 
Jos.  
Materials and methods: Five commonly used brands of ND LaSota live 
vaccines were used for the study. Haemagglutination test (HA) and Egg 
Infective Dose (EID50) was carried out on the vaccines.Sixty (60) day-old 
unvaccinated white leghorn broilers were distributed into 6 groups n=10 and 
allowed to acclimatize for 6 days. Groups 1-5 were vaccinated intraoculally 
with vaccines coded A - E respectively, while group 6 was not vaccinated 
(control group).  They were bled on days 7, 14, 21 and 28 post vaccinations 
(PV) for antibody titration using standard methods. They were challenged 
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with a velogenic strain (105.5 CID50) of NDV day 35 and observed for 
morbidity and mortality for 14 days.  
Results: HA test revealed viral titres of 7log2-9log2 for vaccines with egg 
infectivity dose (EID50) of 107.00 to 108.49.  There was progressive increase in 
antibody titre following vaccination. There were 100% mortalities among the 
control group and non in test groups. Performance of the indigenous vaccine 
was commendable.  
Conclusion: we therefore, conclude that the vaccines sold at Jos, Plateau 
State are potent and could prevent NDV infection and they are reliable, if 
standard protocols are observed. The use of the indigenous vaccine brand 
should also be encouraged to prevent introduction of a new strain into the 
country.  
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Introduction 
 Newcastle disease (ND) is a highly contagious and commonly fatal 
viral poultry disease affecting mainly domestic and wild avian species 
(Spradbrowet al., 1990). The disease caused by Newcastle disease virus 
(NDV); an avian paramyxovirus serotype designated APMV-1. APMV-1 is 
further classified into three pathotypes based on their virulence in chickens 
which are: lentogenic, mesogenic and velogenic (OIE 2004 andAlexander, 
2003). The disease is characterized by respiratory symptoms such as 
coughing, gasping, sneezing and rales. Other signs include dropping wings, 
dragging legs, swelling of tissues around neck and eyes, twisting of the neck, 
circling and cessation of egg production (Wakamatsu et al.,2006). Human 
infections via exposure to infected birds can cause mild conjunctivitis and 
influenza-like symptoms and in severe cases, it can lead to some lasting 
impairment of vision (Beard et al., 1984). 
 Newcastle disease is worldwide in distribution (Chu and Rizk 1972), 
causing an epizootic problem in Nigeria (Ezeokoliet al., 1994 and Olabodeet 
al., 1992) and as such having great negative economic impact in the nation. 
The presence of this virus can also limit trade and the development of intense 
poultry production resulting to major constraint to the availability of protein 
for human consumption (Nwankitiet al., 2010).    
 The disease has no cure; however, the control of the disease relies on 
the regular use of safe and effective vaccines (Spradbrow 1992). Live 
vaccines prepared with lentogenic strains of NDV are commonly used for 
broilers than vaccines prepared from chemically inactivated strains, mixed 
with adjuvant (Alexander 1997 andBigget al., 1988). Freeze-dried NDV live 
vaccines can be produced on a large scale at a relatively low cost. The 
vaccines are easy to administer on a large scale, and rapidly stimulate 
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humoral, cell-mediated and mucosal immunity (Chandraseker et al., 1989, 
Perry and Aitken 1973). 
 Despite the continuous use of NDV vaccine in poultry confinements 
for the control of the disease, pocket of infection have been reported in 
vaccinated flocks (Roy et al., 2000). Vaccine failure may be responsible for 
such outbreak. It has caused many farmers to lose confidence in locally 
produced vaccines, whereby, avoiding the indigenous brand questioning its 
efficacy. The poultry farmers prefer to vaccinate their birds with imported 
vaccines. It therefore, became necessary to verify the potency and efficacy of 
the locally produced vaccines, comparing with foreign brands and give 
appropriate recommendation to the relevant agency. 
 
Materials and Methods  
Sample source and size: 
 Five different brands of Newcastle disease LaSota Live (NDV-LL) 
Vaccines sold at the metropolitan market of Jos, Plateau State of Nigeria 
were obtained from major veterinary stores. The brands include HIPRA, 
IZOVAC, INDOVAC, ABIC and NVRI represented as A, B, C, D and E. 
The vaccines obtained and transferred under cold chain and standard bio-
safety practice to the virology laboratory, NVRI Vom. One of these vaccine 
brands is an Indigenous brand (NVRI), others from Spain,Isreal, Italy, India 
etc. 
 
Day old chickens and Specific pathogen free eggs 
 Sixty(60)unvaccinated day-old leghorns broiler chickens where 
obtained from the animal livestock department, National Veterinary 
Research Institute, Vom,  Plateau State of Nigeria and housed in the 
experimental animal house of the institute. 9days old embryonated specific 
pathogen free eggs were also obtained from hatchery section of this research 
institute. The study location is situated at the northern middle belt of Nigeria; 
Longitude 8o37’30’’and latitude 9o 45’50’.  
 
Egg infective dose at 50% (EID50) and haemagglutination (HA) test. 
 The EID50 of the various brands of vaccine were determined using 
the technique by Reed and Muench1938). HA tithe were determined by 
treating a serially diluted 50µl of each vial suspension with 50µl of 0.5% of 
chicken red blood cells in saline and incubated at room temperature 
(28±1oC) according to method described by Allan and Gough (1974). 
 
Treatment 
 During the entire study the broilers were fed with feeds carefully 
compounded to meet 23% crude protein (CP) and 3200Kcal. Metabolizable 
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energy (ME) for broilers, starter and 20% CP and 3000Kcal for broiler 
finisher, it was ensured that the level of mycotoxins in feed were maintained 
relatively low throughout the experiment, the quality and quantity of 
groundnut cake (GNC), soya bean and rice bran included in the feeds were 
determined by biurette method (Ranja 1999) while the Metabolizable energy 
was determined by the Bomb Calorimeter method (AOAC 1980). The 
broilers were housed in battery cages of 0.31 m 2/ bird as recommended by 
Mustafa et al. (2010). All experimental protocols complied with NIH 
guidelines(National Research Council, 1985) as approved by the ethical and 
research committee, NVRI, Vom. They all received all necessary 
medications, allowed to acclimatize for 6days, fed with standard feeds and 
water ad libitum.  The birds where distributed to six groups (A, B, C D, E 
and F) n=10 caged separately. Group F is the control group. All groups 
except Group F were administered a corresponding vaccineintraocularly 
(0.003ml dropper), and booster dose intramuscularly with 0.1ml of NDV 
komoroffon day 21. All Groups were challenged intra muscularly with 0.1ml 
of a velogenic field strain of NDV (105.5 chicken infective dose) on the 35th 
day post vaccination. The birds were observed for morbidity and mortality 
for another 14days.  
 
Antibody assay 
 Venous blood was harvested from the wing veins on day 1, 7, 14, 21 
and 28 post vaccinations, allowed to clot and serum separated using bench 
centrifuge at 1500r. p. m for 10 min. They were assay to determine HI titre 
for NDV antibody according to protocol described in OIE, Terrestrial 
Manual (2004). However, the birds were bled before vaccination on day 1as 
pre vaccination titre. 
 
Statistical analysis 
 The data collated from the study in various treatment groups were 
statistically analyzed using one way analysis of variance (ANOVA). 
Significant differences between the treatment means were determined at 99% 
confidence level. 
 
Result  
 The HA titre, EID50 and percentage mortality of the tested vaccines 
are shown on table 1. The HA titre of the vaccines were adequate, ranging 
from 7log2 to 9log2. The EID50 of the various brands of vaccines were also 
higher than the 106.5/dose minimum virus level for ND LL vaccines. The 
mortality rate following viral challenge was 100% in control group and there 
was no loss in groups vaccinated with Vaccines A, B, C, D and E. 
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 The pre and post vaccination antibody titre (log2) of broiler 
chickens are shown on table 2. The pre vaccination antibody titre (baseline) 
of the broilers was insignificant (<2log2) in all the groups. On day 14 post 
vaccination, the antibody was observed to be increased showing significant 
titre (>4log2) in all the groups except group D (ABIC) which recorded 
3.8log2. On day 28, the titre was higher in A (HIPRA) and E (NVRI) and 
least in D (ABIC) which recorded 7.3log2. The titre of the control group was 
not significant (<4log2) throughout the period of study. There was however, 
no statistically significant difference in the antibody titre produced by the 
various vaccinated groups at P = 0.01 on the various days.  
 
Discussion 
 The safety of vaccines should be carefully monitored, starting early 
in the production development and continuing for as long as the vaccine is 
being used. Pharmacovigilance should be encouraged to determine the 
adverse events following vaccination of birds. It has been earlier documented 
that vaccines preventable infection have decreased and the spotlight of public 
health media concern has shifted to vaccine safety (Hofacre 1986). 
 The result of the current study yielded suggestion that there is no 
justification to continue to rely on the imported ND LL vaccine, since the 
locally produced one is reliable. It also suggests the discontinuous reliance 
on imported NDV vaccine because of likely variations in field strains, if the 
storage chain is broken unnoticed or unintentionally; it may lead to revert of 
genomics and may introduce a new strain of NDV to the community. 
 Instead of distancing themselves from the use of locally produced 
vaccine because of the perceived failure or pocket of adverse reactions. 
Healthcare providers should report without delay all serious or unexpected 
adverse events following vaccination to the public health officer or 
veterinarian who will in turn transmit same to the government agency 
handling vaccine pharmacovigilance in Nigeria. However, the event (either 
seriously or adverse) following vaccination may be a side effect of the 
vaccine, since all drug/ vaccine have side effects. 
 The immunity observed in vaccinated birds indicated that the 
vaccines were potent. The antibody titre built-up in the tested birds was 
significant and certified the minimum viral level for ND LL vaccines. The 
two fold increase in humoral responses of the birds following ‘primer dose’ 
and ‘booster dose’ was commeasurable with the efficacy of the imported 
vaccines and the corresponding HAtitre. This is in tandem with the work of 
Abbas et al. (2006), Spardbrowet al. (1988) and Alexander (2003), who in 
their various report documented on NDV dose–response relationship among 
the virus content, serological response and clinical protection. It is also in 
agreement with the report of Muhammedet al. (2006) and Chandrasekaret al. 
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(1989), who in separate documentations, stated that there is unusual gradual 
increase in ND antibody titre following the primer vaccination and a higher 
response to a secondary booster dose. 
 The mean HItitre was 6.1log2 (6.5log2 – 5.6log2) on day 21, it was 
significant and sufficiently high to confer immunity against NDV on the 
birds, thereby protecting them from adverse effect of the challenge strain. 
This finding is also in tandem with the work of Allan et al. (26) who reported 
a mean HI titre of 5.2log2 as adequate against NDV infection. The mortality 
rate was 100% in unvaccinated birds because they were not protected either 
with primary or secondary dose of the vaccine. The significant effect of 
vaccines could be explained by the principle of active immunization against 
infectious diseases in the management and control of viral infection in 
poultry birds. The clinical signs following challenge of both vaccinated and 
unvaccinated groups further substantiate the effect of vaccines on the 
management of poultry diseases. This report is not at variance with the 
earlier report of Ojiezehet al. (2013) who highlighted the relevance of 
vaccination in disease prevention, control and management and stated that 
vaccine produced locally are potent against NDV disease.  
 Among the five vaccines tested, HIPRA and NVRI performance 
was higher followed by IZOVAC and INDOVAC. Though, ABIC was a 
performing vaccine but with a lower antibody titre of 5.60 ± 0.54 on day 21 
and 7.30 ± 0.21 on day 28. This devalue may not be unconnected to poor 
handling of the vaccine on storage. 
 
Conclusion 
 The vaccine produced locally is potent and efficient against NDV 
infections in poultry. Farmer should be encouraged to patronize the locally 
produced vaccines and report adverse event following vaccination to 
stakeholders in pharmacovigilance group especially when cold chain-
biosafety protocol have not been compromised. The performance of locally 
produced NDV vaccine is commendable.  
 
 Recommendation 
• Continuous monitoring of the safety of vaccines sold in open 
markets in Nigeria. 
• Identify increases in the frequency and severity of previously 
identified vaccine-related reactions. 
• Identify previously unknown adverse event following immunization 
that could possibly be related to a vaccine. 
• Identify areas that require further investigation and/or research. 
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• Provide timely information on adverse events following vaccination 
reporting profiles for vaccines marketed in Nigeria, that can help 
inform immunization-related decisions. 
• Formation of vaccine vigilance working groups whose responsibility 
would include: 
o Preparation of national guidelines and procedures for 
monitoring and management of adverse effect following 
vaccines. 
o Provide national form to  identify, share and promote best 
practices regarding vaccine pharmacovigilance and 
o Provide a national vaccine safety sentinel network that can 
rapidly share and disseminate information to appropriate 
stakeholders regarding vaccine safety issues and signals. 
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Table 1:Haemagglutination (HA) titre, Egg infective dose at 50% (EID50), and Mortality 
percentage 
Vaccine HA titre (log2) 
EID50 (log10) 
Percentage 
Mortality (%) 
HIPRA 8 8.5 0 
IZOVAC 7 7.7 0 
INDOVAC 7 7.4 0 
ABIC 9 7.0 0 
NVRI 8 8.7 0 
CONTROL Nil Nil 100 
 
Table 2: Antibody titre post vaccination (log 2) of broiler chickens 
Group Day 0 Day 7 Day 14 Day 21 Day 28 
A <2 2.30 ± 0.48 4.30 ± 0.68 6.40 ± 0.52 8.00 ± 0.15 
B <2 2.60 ± 0.52 4.10 ± 0.32 6.10 ± 0.94 7.60 ± 0.27 
C <2 2.50 ± 0.71 4.00 ± 0.67 5.70 ± 0.48 7.40 ± 0.22 
D <2 2.10 ± 0.57 3.80 ± 0.42 5.60 ± 0.54 7.30 ± 0.21 
E <2 2.80 ± 0.42 4.50 ± 0.71 6.50 ± 0.97 8.10 ± 0.23 
F <2 <2 <2 <2 <2 
• <4log2 is insignificant titre. 
• >4log2 is significant titre. 
• All values are means ± SEM of 10 birds per group. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
